help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, B.
Right arrow Articles by Mendelson, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, B.
Right arrow Articles by Mendelson, C. R.
Molecular Endocrinology 14 (10): 1661-1673
Copyright © 2000 by The Endocrine Society

Hypoxia Prevents Induction of Aromatase Expression in Human Trophoblast Cells in Culture: Potential Inhibitory Role of the Hypoxia-Inducible Transcription Factor Mash-2 (Mammalian Achaete-Scute Homologous Protein-2)

Bing Jiang, Amrita Kamat and Carole R. Mendelson

Departments of Biochemistry (B.J., A.K., C.R.M.) and Obstetrics & Gynecology (C.R.M.) The University of Texas Southwestern Medical Center at Dallas Dallas, Texas 75390-9038

The human placenta has a remarkable capacity to aromatize C19-steroids, produced by the fetal adrenals, to estrogens. This reaction is catalyzed by aromatase P450 (P450arom), encoded by the CYP19 gene. In placenta, CYP19 gene expression is restricted to the syncytiotrophoblast layer. Cytotrophoblasts isolated from human placenta, when placed in monolayer culture in 20% O2, spontaneously fuse to form syncytiotrophoblast. These morphological changes are associated with a marked induction of aromatase activity and CYP19 gene expression. When cytotrophoblasts are cultured in an atmosphere containing 2% O2, they manifest increased rates of DNA synthesis and fail to fuse and form syncytiotrophoblast. The objective of the present study was to utilize cytotrophoblasts isolated from midterm human placenta to analyze the effects of O2 on CYP19 gene expression and the molecular mechanisms that mediate these effects. We observed that when trophoblast cells were maintained in 2% O2, there was only a modest induction of CYP19 expression as a function of time in culture, and aromatase activity was barely detectable. However, when cytotrophoblasts that had been maintained in 2% O2 for 3 days were placed in a 20% O2 environment, there was a rapid onset of cell fusion and induction of P450arom mRNA and aromatase activity. In addition, mRNAs for the helix-loop-helix factors Mash-2 (mammalian achaete-scute homologous protein-2) and Id1 (inhibitor of differentiation 1) were readily detectable in freshly isolated cytotrophoblasts and were markedly decreased upon differentiation to syncytiotrophoblast in 20% O2. By contrast, when cytotrophoblasts were cultured in 2% O2, mRNA levels for Mash-2 and Id1 remained elevated. Interestingly, overexpression of Mash-2 in primary cultures of human trophoblast cells markedly inhibited cell fusion and the spontaneous induction of P450arom mRNA levels and caused a marked decrease in expression of cotransfected fusion gene constructs containing either 125, 201, 246, or 501 bp of DNA flanking the 5'-end of the placenta-specific exon (exon I.1) of the human CYP19 gene linked to the human GH (hGH) structural gene, as reporter. In studies using BeWo, a human choriocarcinoma cell line, overexpression of Mash-2 also inhibited expression of cotransfected CYP19I.1:hGH fusion gene constructs. The findings that Mash-2 had no effect on the expression of a CYP19I.1-42:hGH fusion gene in primary cultures of human trophoblast and BeWo cells suggest that Mash-2 exerts its inhibitory effects directly or indirectly though CYP19I.1 5'-flanking sequences that lie between -42 and -125 bp. By contrast, neither Id1 nor Id2 had an effect on CYP19I.1 promoter activity in the transfected BeWo cells. These findings suggest that Mash-2 may serve as a hypoxia-induced transcription factor that prevents differentiation to syncytiotrophoblast and aromatase induction in human trophoblast cultured under low O2 conditions.




This article has been cited by other articles:


Home page
EndocrinologyHome page
D. Liu, M. M. Hinshelwood, V. Giguere, and C. R. Mendelson
Estrogen Related Receptor-{alpha} Enhances Surfactant Protein-A Gene Expression in Fetal Lung Type II Cells
Endocrinology, November 1, 2006; 147(11): 5187 - 5195.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. D. Gultice, K. L. Selesniemi, and T. L. Brown
Hypoxia Inhibits Differentiation of Lineage-Specific Rcho-1 Trophoblast Giant Cells
Biol Reprod, June 1, 2006; 74(6): 1041 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. N. Islam and C. R. Mendelson
Permissive Effects of Oxygen on Cyclic AMP and Interleukin-1 Stimulation of Surfactant Protein A Gene Expression Are Mediated by Epigenetic Mechanisms
Mol. Cell. Biol., April 15, 2006; 26(8): 2901 - 2912.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J.L. James, P.R. Stone, and L.W. Chamley
The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy
Hum. Reprod. Update, March 1, 2006; 12(2): 137 - 144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. D. Cowden Dahl, B. H. Fryer, F. A. Mack, V. Compernolle, E. Maltepe, D. M. Adelman, P. Carmeliet, and M. C. Simon
Hypoxia-Inducible Factors 1{alpha} and 2{alpha} Regulate Trophoblast Differentiation
Mol. Cell. Biol., December 1, 2005; 25(23): 10479 - 10491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Jiang and C. R. Mendelson
O2 Enhancement of Human Trophoblast Differentiation and hCYP19 (Aromatase) Gene Expression Are Mediated by Proteasomal Degradation of USF1 and USF2
Mol. Cell. Biol., October 15, 2005; 25(20): 8824 - 8833.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al.
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kamat, M. E. Smith, J. M. Shelton, J. A. Richardson, and C. R. Mendelson
Genomic Regions that Mediate Placental Cell-Specific and Developmental Regulation of Human Cyp19 (Aromatase) Gene Expression in Transgenic Mice
Endocrinology, May 1, 2005; 146(5): 2481 - 2488.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Jiang and C. R. Mendelson
USF1 and USF2 Mediate Inhibition of Human Trophoblast Differentiation and CYP19 Gene Expression by Mash-2 and Hypoxia
Mol. Cell. Biol., September 1, 2003; 23(17): 6117 - 6128.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Stepan, W. Marqwardt, Y. Kuhn, M. Hockel, H.-P. Schultheiss, and T. Walther
Structure and Regulation of the Murine Mash2 Gene
Biol Reprod, January 1, 2003; 68(1): 40 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. B. Hardy and K. Yang
The Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Is Induced during Trophoblast Differentiation: Effects of Hypoxia
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3696 - 3701.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Tarrade, K. Schoonjans, L. Pavan, J. Auwerx, C. Rochette-Egly, D. Evain-Brion, and T. Fournier
PPAR{gamma}/RXR{alpha} Heterodimers Control Human Trophoblast Invasion
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5017 - 5024.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society